Clinical Trial Update: GlitazOne Treatment for Coronavirus HypoxiA, a Safety and Tolerability Open Label With Matching Cohort Pilot Study [Phase 4]

View source ↗

Summary

A Phase 4 open-label safety and tolerability study with a matching cohort pilot evaluating GlitazOne for coronavirus hypoxia in patients with diabetes, complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronavirus Infection
• Diabetes

Drugs mentioned

• Glitazone

Snippet

Sponsor: Samaritan Health Services | Conditions: Coronavirus Infection, Diabetes | Phase 4 | Status: COMPLETED